Patents by Inventor James W. Baumgartner

James W. Baumgartner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030100046
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular domain of a cell-surface receptor that is expressed in testis cells. The polypeptides may be used within methods for detecting ligands that promote the proliferation and/or differentiation of testis cells, and may also be used in the development of male-specific contraceptives and infertility treatments.
    Type: Application
    Filed: March 12, 1997
    Publication date: May 29, 2003
    Inventors: JAMES W. BAUMGARTNER, THERESA M. FARRAH, DONALD C. FOSTER, FRANK J. GRANT, PATRICK J. O'HARA
  • Publication number: 20030100047
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular domain of a cell-surface receptor that is expressed in testis cells. The polypeptides may be used within methods for detecting ligands that promote the proliferation and/or differentiation of testis cells, and may also be used in the development of male-specific contraceptives and infertility treatments.
    Type: Application
    Filed: June 4, 1998
    Publication date: May 29, 2003
    Inventors: JAMES W. BAUMGARTNER, THERESA M. FARRAH, DONALD C. FOSTER, FRANK J. GRANT, PATRICK J. O'HARA
  • Patent number: 6169974
    Abstract: A procedure for tracking transactions carried out between multiple cost centers and an in-house supply facility of a business entity is carried out by setting up the supply facility to function essentially in the same manner as an independent retail merchant through the existing bank card association. Transaction information is then transferred as a batch to a merchant accounting system which transfers the information to the bank card association to the card issuer. The card issuer then provides a funds payment that is transferred through the bank card network to the merchant accounting system and finally to the merchant acquirer. The merchant acquirer, however, then transfers the funds back to the credit card issuer to cancel out the original funds transfer and thereby provide a closed loop funds transfer.
    Type: Grant
    Filed: October 8, 1998
    Date of Patent: January 2, 2001
    Assignee: Paymentech, Inc.
    Inventors: James W. Baumgartner, Cynthia M. Smith
  • Patent number: 6080406
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular ligand-binding domain of a cell-surface receptor that is expressed at high levels in lymphoid tissue, including B-cells and T-cels. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo.
    Type: Grant
    Filed: March 24, 1999
    Date of Patent: June 27, 2000
    Assignee: ZymoGenetics, Inc.
    Inventors: James W. Baumgartner, Donald C. Foster, Frank J. Grant, Cindy A. Sprecher
  • Patent number: 5925735
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular ligand-binding domain of a cell-surface receptor that is expressed at high levels in lymphoid tissue, including B-cells and T-cells. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo.
    Type: Grant
    Filed: May 6, 1998
    Date of Patent: July 20, 1999
    Assignee: ZymoGenetics, Inc.
    Inventors: James W. Baumgartner, Donald C. Foster, Frank J. Grant, Cindy A. Sprecher
  • Patent number: 5792850
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular ligand-binding domain of a cell-surface receptor that is expressed at high levels in lymphoid tissue, including B-cells and T-cells. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo.
    Type: Grant
    Filed: May 23, 1996
    Date of Patent: August 11, 1998
    Assignee: ZymoGenetics, Inc.
    Inventors: James W. Baumgartner, Donald C. Foster, Frank J. Grant, Cindy A. Sprecher